8-K ·Filed Jun 16, 2026

HUN

Huntsman CORP
BULLISH
Impact 7/10
Horizonmonths Processed3mo ago SEC0001104659-26-074266
8-K context-dependent: Items 7.01
Actionable Insight ▲ Bullish

The merger creates a larger, more integrated chemicals platform with significant synergy potential. Traders should monitor regulatory filings and shareholder votes over the coming months. The deal's all-stock structure means relative performance of HUN and OLN will be linked to the exchange ratio and market perception of synergy delivery.

DirectionBullish
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
HUN ▼ -27.69% at T+60d
LONG call ✗ call lost -27.69% · α vs SPY -28.69% · entry $13.18 → $9.53
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
-3.41%
call -3.41% · α -2.17%
$12.73
settled 4mo ago
T+5d
-13.66%
call -13.66% · α -11.42%
$11.38
settled 3mo ago
T+20d
-9.64%
call -9.64% · α -9.84%
$11.91
settled 3mo ago
T+60d
-27.69%
call -27.69% · α -28.69%
$9.53
settled 21d ago

Price Chart

Loading chart...

Executive Summary

Huntsman and Olin announced a definitive all-stock merger of equals to create OlinHuntsman Corporation, a combined North American chemicals leader with ~$12.5B in 2025 revenue. Huntsman shareholders will receive 0.5476 Olin shares per HUN share, representing ~45.5% ownership of the combined entity. The deal is expected to close in H1 2027, subject to regulatory and shareholder approvals, with $400M+ in identified cost synergies.

Key Facts

  • All-stock merger of equals; Huntsman shareholders receive 0.5476 Olin shares per HUN share.
  • Post-merger ownership: Olin shareholders ~54.5%, Huntsman shareholders ~45.5%.
  • Combined 2025 revenue of approximately $12.5 billion.
  • Identified $400M+ in cost synergies and integration benefits ($300M+ within 3 years, additional $100M in 2031).
  • Expected ~$125M in cash tax benefits from accelerated NOLs.
  • Ken Lane (Olin CEO) to be CEO of combined company; Peter Huntsman to be non-executive Chairman.
  • Transaction expected to close in H1 2027, subject to regulatory and shareholder approvals.

Financial Impact

Combined 2025 revenue ~$12.5B; $400M+ annual cost synergies; ~$125M cash tax benefits.

revenuecost synergiescash tax benefits

Risk Factors

  • Regulatory approval risk (antitrust review in multiple jurisdictions).
  • Shareholder approval risk at both companies.
  • Integration execution risk and potential for lower-than-expected synergies.
  • Cyclical downturn in chemicals could delay benefits.

Market Snapshot

Exchange
NYSE
Sector
Chemicals & Allied Products
Analyst Consensus
9% bullish (23 analysts)

Investment Themes

Materials & Mining

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-074266
Document: tm2618028d2_ex99-1.htm0001104659-26-074266
Document: tm2618028d2_ex99-2.htm0001104659-26-074266
Document: 0001104659-26-074266-index-headers.html0001104659-26-074266
Document: 0001104659-26-074266-index.html0001104659-26-074266
Document: 0001104659-26-074266.txt0001104659-26-074266
23 reports for HUN
Performance horizon
25% Hit rate 2 of 8 directional calls best @ T+1▲ +4.09%Aug 3, 2026
Filters
Rows
Reports for HUN — sortable, filterable
TypeNow
Aug 25, 2026
5w ago
8-K
BULLISH ★ 6/10
$9.63 $8.86▼ −8.00%▼ −9.20%$8.53 (−11.42%)
Aug 3, 2026
8w ago
Insider Buy
BULLISH ★ 4/10
$10.02 $9.58▼ −4.39%▼ −5.63%$8.53 (−14.87%)
Jul 31, 2026
8w ago
425
NEUTRAL ★ 5/10
$10.02 $9.58▼ −4.39%▼ −5.63%$8.53 (−14.87%)
Jul 31, 2026
9w ago
425
NEUTRAL ★ 5/10
$10.02 $9.58▼ −4.39%▼ −5.63%$8.53 (−14.87%)
Jul 14, 2026
11w ago
425
NEUTRAL ★ 5/10
$11.91 $10.44▼ −12.34%▼ −14.83%$8.53 (−28.38%)
Jul 13, 2026
11w ago
425
NEUTRAL ★ 5/10
$11.61 $10.36▼ −10.77%▼ −13.95%$8.53 (−26.53%)
Jul 13, 2026
11w ago
425
NEUTRAL ★ 5/10
$11.61 $10.36▼ −10.77%▼ −13.95%$8.53 (−26.53%)
Jun 25, 2026
14w ago
425
NEUTRAL ★ 3/10
$11.41 $12.81▲ +12.27%▲ +11.01%$8.53 (−25.24%)
Jun 17, 2026
15w ago
425
NEUTRAL ★ 4/10
$12.73 $11.86▼ −6.83%▼ −8.15%$8.53 (−32.99%)
Jun 16, 2026
15w ago
425
NEUTRAL ★ 4/10
$12.73 $11.86▼ −6.83%▼ −8.15%$8.53 (−32.99%)
Showing 10 of 23

US Market Status

Market Closed — Opens Mon (64h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access